Company / AR per Share
Protalix BioTherapeutics, Inc. AR per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
$0.12
FY2025
5-year range
$0.04 / $0.12
FY2021-FY2025
Trend
+192.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
AR per Share returned to growth in FY2025 after 2 years of decline, reaching $0.12.
Based on SEC 10-K filings.
0.12 in FY2025 with a 5-year CAGR of -2.9%.
Improved from $0.10 to $0.12 over the past 2 years.
AR per Share over time
Growth rates
- 3-Year CAGR
- +5.0%
- 5-Year CAGR
- -2.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, ar per share increased 192.3% year-over-year.
- Peak ar per share was recorded in FY2019.
- Lowest ar per share in the period was in FY2016.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.12 | +192.3% |
| FY2024 | $0.04 | -59.3% |
| FY2023 | $0.10 | -2.6% |
| FY2022 | $0.10 | +1.7% |
| FY2021 | $0.10 | -26.5% |
| FY2020 | $0.13 | -57.4% |
| FY2019 | $0.32 | +2184.7% |
| FY2017 | $0.01 | +99.7% |
| FY2016 | $0.01 | - |
| FY2015 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026